Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TJ107 for efficacy and safety in lympopenic patients with newly diagnosed glioblastoma who completed standard chemoradiotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• TJ107

Snippet

Sponsor: TJ Biopharma Co., Ltd. | Conditions: Newly Diagnosed Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING